NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ:

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
187
NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Publishes Q2 2024 Results

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today released its financial results for the second quarter ended June 30, 2024 (“Q2 2024”). The company also discussed the clinical development progress of Berubicin, its lead program, and TPI 287, its recently in-licensed abeotaxane for the treatment of brain malignancies. CNS Pharmaceutical expects to be able to release final topline data from its potentially pivotal trial of Berubicin in the first half of 2025. The trial is evaluating Berubicin in adult patients with recurrent glioblastoma multiforme (WHO Grade IV) after failure of standard first-line therapy. Additionally, the company plans to engage the U.S. FDA to seek guidance on advancing TBI 287 into a potential registration study of recurrent GBM.

The financial results for Q2 2024 included a net loss of approximately $2.5 million compared to approximately $4.0 million for the comparable period in 2023, R&D expenses of $1.1 million for Q2 2024 versus approximately $2.8 million for Q2 2023, and general and administrative expense of $1.4 million for Q2 2024 compared to approximately $1.2 million for Q2 2023. As of June 30, 2024, CNS Pharmaceuticals had cash of approximately $1.5 million. In addition, the company has raised total gross proceeds of approximately $12.4 million in financing between June 30, 2024, and August 14, 2024. As a result, the company has sufficient cash to fund its operations through the first quarter of 2025.

NOTE TO INVESTORS: The latest news and updates relating to CNSP are available in the company’s newsroom at https://nnw.fm/CNSP

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or republished: http://NNW.fm/Disclaimer

CNS Pharmaceuticals Inc. (CNSP) Stock Research Links

CNSP Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

OneAscent Welcomes Monica Stoudemire as New CCO

Updated Category News Views 3

New Leadership in Compliance Diving straight into the tumultuous sea of securities compliance, OneAscent's got a fresh captain at the helm. Monica Stoudemire's stepped into the Chief Compliance Officer's shoes with a track record that'd make any investor breathe a sigh of relief. After all, blending two decades of on-the-ground experience with regulatory acumen ain't...

Continue Reading
Navigating Land Access: The Hidden Roadblock in Mining

Updated Category News Views 3

Mining's Often Overlooked Obstacle: Land Access In the world of mining, the shallow thrills of striking gold are often overshadowed by the frustrating slog of securing land access. You can have your permits lined up, your finances sorted, and drills humming along, but if you haven’t sweet-talked the folks farming above your visible vein of riches, you could be staring...

Continue Reading
Rare Collectibles Highlight Morphy's Auction on Oct 4

Updated Category News Views 2

Anticipation Builds for Morphy's Auction Event Morphy's upcoming event on October 4th is all about tapping into the era of revved engines, gleaming gasoline signs, and some history that could put Hollywood tales to shame. The auction isn't just a stroll down memory lane; it features over 650 lots, each a time capsule of America's automotive past. From Al Capone's ritzy...

Continue Reading
Step Inside Henson's Creature Shop Magic in NYC

Updated Category News Views 1

Unlock Puppet Magic with Jim Henson Tours Puppet fans, let me tell you, there's something going on in Queens, NY that's got both nostalgia and innovation scribbled all over it. We're talking about the legendary Jim Henson's Creature Shop opening its doors. If you're looking to relive the magic that helped shape a generation, get ready to dive into a world where creativity...

Continue Reading
Helio Fred Garcia Honored by Diversity Action Alliance

Updated Category News Views 4

Award Ceremony Set in the Big Apple In an industry where recognition often feels as transient as a ticker's daily high, the Diversity Action Alliance (DAA) is doing its bit to emphasize the lasting impact individuals can make. On September 16 in New York City, Helio Fred Garcia will be honored with the 2026 Pat Ford Larger Than Life Impact Award at the DAA's Annual...

Continue Reading
GBI Bio's New CEO Jesse McCool to Propel Growth

Updated Category News Views 4

Jesse McCool stepping into GBI's CEO shoes is the kind of move that makes you sit up straight and take notice. Let me tell you, the biomanufacturing scene is buzzing with this appointment, and McCool's got his work cut out for him in leading GBI Biomanufacturing's shift towards commercial-scale operations while expanding their early-stage biotech portfolio. A Veteran in...

Continue Reading
Deadline Looms for EquipmentShare Investors' Legal Action

Updated Category News Views 4

Pressure Builds for EquipmentShare Investors If you've thrown some cash into EquipmentShare.com Inc. (NASDAQ: EQPT), it's time to sit up and pay attention. There's smoke on the horizon, and Faruqi & Faruqi, LLP is waving the flag. They've got a securities class action spinning fast, and if you've suffered any losses, September 21, 2026, is a date you don't want to forget....

Continue Reading
Seismic Pharma Kicks Off Phase 3 Trial for Istaroxime

Updated Category News Views 3

Seismic Sets the Stage for a Medical Milestone From the heart of biotech in Durham, North Carolina, seismic waves ripple through the medical community as Seismic Pharmaceuticals embarks on a high-stakes adventure. It's official: they've enrolled their very first patient in the global Phase 3 trial of istaroxime, targeting the grim specter known as cardiogenic shock. You...

Continue Reading
Diaper Affordability: A Hidden Crisis, Taxpayer Burden

Updated Category News Views 6

A Silent Crisis Lurking in Diapers Diapers. We don’t think about them much until we need them, but nearly half of U.S. families are painfully aware of their cost. According to a report from the NDBN Diaper Check 2026, many struggle to meet this basic necessity. This isn't just about keeping babies clean—it's a public health issue with economic ripples Congress can't...

Continue Reading
XKL Delivers MediaLight for High-Speed Optical Transport

Updated Category News Views 2

Unpacking the MediaLight Launch Kicking off September, XKL is tossing its hat in the ring with the MediaLight Xponder and Muxponder systems. These aren't just any run-of-the-mill gizmos—nope, they're touted as top-of-the-line optical transport solutions. The talk of the town is their ability to dish out high-density 100G and 400G transport, and for geeks in the trade,...

Continue Reading

Top 5 Most Recently Viewed Articles

Strategic Leadership Growth at Nowadays with New Director

Updated Category News Views 141

Strategic Leadership Growth at Nowadays with New Director Former TTB Regulatory Leader Tapped to Help Guide the Future of Hemp-Derived THC Beverages Amid Evolving Policy Landscape Nowadays, a fast-growing THC-infused beverage brand, has announced the appointment of Christopher Forster-Smith as its new Director of Regulatory Affairs. In this pivotal role, he will be...

Continue Reading
Exciting Culinary Experiences Await at 2025 Food Festival

Updated Category News Views 271

2025 Nassau Paradise Island Wine & Food Festival Announced The highly anticipated 2025 Nassau Paradise Island Wine & Food Festival is set to return, attracting food enthusiasts with its star-studded lineup of culinary talent. Celebrated chefs such as Bobby Flay, Kardea Brown, Katie Lee, and Michael Symon will headline this extraordinary event, bringing their exceptional...

Continue Reading
Ryp Labs Triumphs in Lineage’s Global Food Innovation Challenge

Updated Category News Views 151

Ryp Labs Triumphs in Lineage’s Global Food Innovation Challenge In a groundbreaking moment for sustainable food technology, Ryp Labs was announced as the standout winner of Lineage's prestigious innovation challenge aimed at transforming the global food supply chain. The challenge focused on innovative solutions that address pressing issues such as food waste and supply...

Continue Reading
Old Point Financial Achieves 52-Week Record Performance

Updated Category News Views 178

Old Point Financial Corporation Soars to New Heights Old Point Financial Corporation (OPOF) has recently made headlines as its stock surged to a remarkable 52-week high, now valued at $20.33. This achievement is not just a number; it symbolizes the growing confidence among investors regarding the company’s financial stability and future growth prospects. Over the past...

Continue Reading
Investigation of Starbucks: Are Investor Rights Being Breached?

Updated Category News Views 256

Starbucks Faces Investigation: What Long-Term Shareholders Need to Know Bragar Eagel & Squire, P.C., a well-known law firm, is currently investigating Starbucks Corporation (NASDAQ: SBUX) on behalf of long-term stockholders. This action follows a class action lawsuit, aimed at determining whether the company's board of directors has acted in the best interests of its...

Continue Reading